This review summarizes recent literature regarding the prevention of central line-associated bloodstream infection (CLABSI).
INTRODUCTION
Healthcare-associated infections (HAIs) are among the top 10 causes of death in the United States. In 2002, an estimated 1.7 million infections and 99 000 deaths were attributable to HAIs [1] . Central lineassociated bloodstream infection (CLABSI) is among the most common HAIs and results in prolonged hospital stays, significant morbidity, and an increase in crude mortality [2] . Wenzel and Edmond estimate that CLABSI was the eighth leading cause of death in the United States in 2001 [3] , and CLABSI is estimated to be associated with approximately $9 million in additional costs annually [4 & ]. CLABSI is also prevalent and associated with great burden internationally, as outlined in a summary from the International Infection Control Consortium (INICC) network, which collects HAI surveillance data from ICUs in Latin America, Asia, Africa, and Europe. Including surveillance data from 2003 to 2008, they found that, while central line utilization rates (the proportion of central line days to total patient days) were similar to those reported in the United States, the rate of CLABSI was nearly 4-fold higher (7.6 per 1000 central line-days in INICC versus 2.0 per 1000 central line-days from comparable ICUs in NHSN) [5, 6] .
CLABSI prevention measures have long had a prominent role in infection control practice and investigation. Initial efforts focused on evidencebased best practices at the time of central line insertion. Subsequent studies evaluated novel technologies to reduce CLABSI including antibiotic or antiseptic-coated catheters, needleless devices, and antiseptic dressings. More recently, prevention efforts have broadened beyond insertion practices to include evidence-based practices for appropriate maintenance of central lines and methods to reinforce a culture of safety in order to implement and sustain central line insertion and maintenance practices. Several large studies have shown that multifaceted quality improvement efforts are effective and sustainable for CLABSI prevention [7-10,11 & ,12] . The Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and Prevention (CDC) published revised CLABSI-prevention guidelines in 2011 [13,14 && ]. Other professional societies and organizations, including the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Institute for Healthcare Improvement (IHI), have published recommendations and implementation guides for CLABSI prevention [15, 16] .
The CDC reported major reductions in CLABSI rates in ICUs in the United States over the 9-year period from 2001 to 2009 based upon data submitted to the CDC's National Healthcare Safety Network (NHSN) from healthcare institutions nationwide. An estimated 43 000 CLABSIs occurred among US ICU patients in 2001, compared with 18 000 in 2009, a 58% reduction [17 && ]. More recently, the CDC reported that US ICU CLABSI rates were 32% lower than expected in 2010 based upon comparison with similar risk and location benchmarks using the standardized infection ratio (SIR). The national CLABSI SIR during 2010 was significantly decreased (SIR 0.684, 32% reduction in CLABSI) compared with 2009 (SIR 0.854, 15% reduction in CLABSI), suggesting not only sustained performance but also continued improvement in 2010 [18] .
The striking reduction in CLABSI rates since the implementation of various prevention initiatives has fostered the idea that CLABSI is largely preventable, and some have suggested that a CLABSI rate of zero is an achievable goal. Stakeholders, including the US Department of Health and Human Services (HHS), The Joint Commission, and the Centers for Medicare and Medicaid Services (CMS), have further developed quality improvement initiatives and CLABSI prevention tools [4 & ]. Recently, HHS set a national goal for a 75% reduction in CLABSI over 5 years [19] . As part of its National Patient Safety Goals, The Joint Commission implemented a new requirement for hospital-wide CLABSI surveillance, to include non-ICU units as well as ICUs, beginning on January 1, 2010 [20] . In addition, CMS initiated a new requirement in 2010 for participating hospitals to report CLABSI rates to the NHSN for adult, pediatric, and neonatal ICU patients [21] . Twentyfour states mandate public reporting of CLABSI rates, and three other states currently have pending legislation [22] .
The objective of this review is to summarize the most recent literature related to CLABSI prevention.
DEFINITION AND PATHOPHYSIOLOGY OF CLABSI
The CDC NHSN defines CLABSI as bacteremia with a recognized pathogen when the organism isolated from blood culture is not related to infection at another site; or isolation of a common skin contaminant from two or more blood cultures associated with signs and symptoms of infection (fever, chills, or hypotension) that cannot be attributed to infection at another site [23, 24] . The CLABSI definition was changed in 2008 to require more stringent criteria for the diagnosis of CLABSI due to a common skin contaminant [24] . The CLABSI rate is expressed as the number of infections per 1000 central line-days.
CLABSI occurs through the extraluminal or intraluminal route, via colonization of the catheter and biofilm formation. The extraluminal route involves organisms at the insertion site, whereas the intraluminal route involves migration of pathogens through the catheter lumen after contamination or colonization of the catheter hub [10] .
KEY POINTS

There has been great success in reducing central lineassociated bloodstream infection (CLABSI) rates in recent years.
Literature on CLABSI prevention has historically focused on multifaceted strategies for central line insertion in the ICU setting.
More recent literature suggests that utilizing a similar multifaceted approach to central line maintenance can result in further reduction of CLABSI and that these insertion and maintenance practices can also be successfully applied to pediatric and neonatal populations and in the non-ICU setting.
Bathing with CHG solution has been shown to be a useful adjunct to infection control measures to reduce CLABSI rates.
More data are needed to develop appropriate benchmarks and prevention strategies specific to the non-ICU setting, in which a significant proportion of central line-days and CLABSI occur.
The extraluminal route of infection seems to be the most common mechanism in short-term catheters [25] , whereas the catheter hub is believed to be the most common source of organisms in long-term catheters (duration more than 7-10 days) [26] . The patient's skin flora is a frequent source of micro-organisms although pathogens can also come from unwashed hands or other environmental sources. There have been cases of hospital-acquired bloodstream infection from contamination of intravenous medications and infusates, more commonly reported in developing countries [27] [28] [29] [30] . A summary of CLABSIs reported to NHSN found that 60% were caused by Gram-positive organisms, including coagulase-negative staphylococci (34%), Enterococcus species (16%) and Staphylococcus aureus (10%). Approximately 18% of the reported CLABSIs were due to Gram-negative organisms, and 12% to Candida species [31] .
PRACTICE CHANGE/QUALITY IMPROVEMENT
CLABSI prevention often requires broad practice changes and implementation of multifaceted programs to improve infection control measures relating to the insertion and care of central lines [7] [8] [9] [10] 11 & ]. It is increasingly recognized that central line insertion checklists alone are not enough to prevent CLABSI; these efforts must be bolstered by education, measuring performance, providing feedback, fostering teamwork, and improvement in the overall safety culture in healthcare.
Multifaceted strategies
A comprehensive approach to CLABSI prevention includes many elements such as improved hand hygiene, use of full-barrier precautions during central line insertion, skin cleansing with chlorhexidine gluconate (CHG), avoidance of the femoral site whenever possible, and prompt removal of unnecessary catheters, in addition to a program of staff education, feedback on performance, and promotion of teamwork [7,8,10,12,14 && , 15, 16] . Several publications in the past 2 years report successful experiences with this type of multifaceted strategy, at both the institution and statewide levels ( Table 1) .
Rhode Island showed a significant reduction in the statewide CLABSI rate in ICUs, from a mean ]. Both of these groups report a median infection rate of zero after implementation of prevention measures. The median infection rate can be a somewhat misleading statistic, however, as it is often zero when a sample of institutions includes facilities in which central line utilization is low and patients are at low risk for CLABSI. In the Hawaii experience, the median CLABSI rate was zero both at baseline and throughout the study period. Reporting a median infection rate of zero can contribute to the notion that complete elimination of CLABSI is possible, whereas this cannot necessarily be generalized to large healthcare facilities with high-risk patients.
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Central line maintenance practices
Best practices for central line insertion are only part of the story, especially when central lines stay in place for an extended period of time. A study conducted at a Veterans Affairs medical center demonstrated reduction in the CLABSI rate with implementation of evidence-based practices for central line maintenance in a setting in which compliance with insertion practices was already high, but the CLABSI rate remained above the national benchmark. Postinsertion care practices in this study included daily inspection of the insertion site; site care if the dressing was found to be wet, soiled, or had not been changed for 7 days; documentation of ongoing need for the catheter; proper application of a CHG-impregnated sponge at the insertion site; performance of hand hygiene before handling the intravenous system; and application of an alcohol scrub of the infusion port for 15 seconds prior to each line access. After implementation of these maintenance practices, the CLABSI rate decreased from 5.7 to 1.1 infections per 1000 central line-days (RR 0.19, 95% CI 0.06-0.63,
. In a United Kingdom study, the median CLABSI rate in the ICU fell from 3.4 per 1000 central line-days to 0 per 1000 central line-days after adopting insertion and maintenance strategies (P ¼ 0.0025). The central line maintenance strategies were similar to the ones outlined above and also included avoidance of three-way ports, use of a dedicated lumen for parenteral nutrition, and discouraging catheter exchange over a guidewire and blood-draws through the central line [37 && ]. Increasingly, CLABSI prevention studies report interventions to monitor and improve both catheter insertion and maintenance practices.
CLABSI prevention in pediatric patients
The CLABSI prevention strategies described in adult ICUs have also been successful in neonatal and pediatric ICU populations. In 2007, 18 neonatal ICUs (NICUs) in New York State adopted common line insertion and line maintenance practices, followed by a 67% statewide decline in CLABSI rates (6.4 versus 2.1 per 1000 central line-days, P < 0.0005). It was noted that the CLABSI rate was dependent upon compliance with the line maintenance checklist, with higher CLABSI rates occurring in units with lower checklist utilization rates [38 & ]. Similar results were achieved in a statewide initiative in California [39] . A NICU study implementing CLABSI-prevention practices based predominantly on the 2002 CDC guidelines showed a decrease in CLABSI rates from 8.4 to 1.7 per 1000 central line-days [40] .
A large prospective surveillance study including nine pediatric ICUs (PICUs) and 1986 patients in developing countries compared CLABSI rates before and after implementation of an infection control program, which included education, evidencebased practices, surveillance, and feedback of data to patient care units. Although there were significantly more central line-days in the postimplementation group, the CLABSI rate was reduced by 52% 
Education and simulated training
Several studies suggest that simulation-based training on sterile technique during central line insertion is effective to improve provider skill and contribute to reduction in CLABSI rates [43 & ,44] . One group of investigators estimated an annual net savings of approximately $700 000 after implementation of a $112 000 per year simulation training program on central line insertions in the medical ICU (MICU) [45] .
Recently, Cherry et al. [46 && ] showed a significant reduction in the CLABSI rate (from 3.6 to 2.3 CLABSIs per 1000 central line-days, P ¼ 0.015) after implementation of a medical resident oversight and credentialing policy in an academic medical center. The training included a simulated experience in central line insertion, review of evidence-based best practices, watching a New England Journal of Medicine training video [47] , and direct supervision of at least five central line insertions at a given anatomic site [46 && ]. A recent study determined that a web-based training course on CLABSI prevention increased clinicians' knowledge about CLABSI and much of this knowledge was retained after 3-4 months, based on pretest and posttest quiz scores [48] .
Implementation and culture change
Significant attention has been paid to creating a culture change as part of CLABSI prevention initiatives. A national program based upon the concept of a Comprehensive Unit-Based Safety Program (CUSP), known as 'On the CUSP: Stop BSI', involves educating clinicians about CLABSI and empowering them to work toward preventing these infections, providing necessary tools to support the change, strategies to identify and overcome barriers to compliance with the measures, and interventions to improve teamwork [49, 50] . Using a national survey of 250 hospitals reporting CLABSI rates to NHSN, Furuya et al. [51] developed statistical models to determine which aspects of a CLABSI prevention program (having a policy, monitoring compliance with the policy, level of compliance with the policy) are associated with a reduction in CLABSI. They determined that, in order to achieve a significant reduction in CLABSI rate, an ICU had to have a comprehensive policy in place, monitor compliance with the policy, and have at least 95% compliance with at least one element of the multimodal strategy [51] .
Several recent studies have suggested that developing a formalized system (e.g. having a dedicated line insertion or maintenance team) may facilitate translation of guidelines into practice. The implementation of a line maintenance team in a NICU to standardize line maintenance practices was followed by a reduction in the CLABSI rate from 11.6 to 4.0 infections per 1000 central line-days (P < 0.001). The team was composed of nurses who received formalized education about the evidence-based practices for line management and subsequently performed all line maintenance measures on the unit [52 && ]. Another study also showed a similar reduction in CLABSI rates in the NICU setting after implementation of a line team dedicated to central line maintenance [53] . Taylor et al. [54 && ] studied the effect of a line team dedicated to both central line insertion and maintenance in the NICU, and found a significant reduction in the risk of CLABSI for neonates with long-term catheters (hazard ratio (HR) 0.48, 95% CI 0.25-0.91, P ¼ 0.025). A similar standardized line maintenance team approach has also been shown to reduce the CLABSI rate among pediatric hematopoietic stem cell transplant recipients [55] .
CLABSI SURVEILLANCE AND PREVENTION OUTSIDE OF THE INTENSIVE CARE UNIT
For years, almost all CLABSI surveillance efforts and prevention studies have been limited to the ICU setting. However, recently more attention has been paid to the fact that central lines are commonly used in non-ICU settings. One-third or more of all central line-days may occur outside of the ICU [56] [57] [58] [59] . One study found that non-ICU medical wards have significantly lower device utilization rates than MICUs, but similar CLABSI rates [60] . The focus outside of the ICU was highlighted by the 2010 requirement by The Joint Commission for hospital-wide CLABSI surveillance. Data are just beginning to emerge about CLABSI outside of the ICU, and more investigation is needed to establish appropriate benchmarks and to determine whether the same CLABSI prevention approaches are effective and sustainable in non-ICU settings.
Recent studies suggest that the same prevention strategies are useful in non-ICU settings. Marra et al. [61 && ] showed a reduction in CLABSI rate from 4.1 to 1.6 infections per 1000 central line-days (P ¼ 0.005) in two step-down units applying the same prevention strategy utilized in ICUs. A study conducted on the general wards of two small community hospitals found that the utilization of a central line insertion checklist hospital-wide for all central line insertions resulted in a similar decline in CLABSI rate on the general wards as in the ICU. Overall, 60% of the CLABSIs occurred in the non-ICU setting, and 79% of central line-days occurred in the non-ICU setting in this report [62 && ].
SKIN ANTISEPSIS
As one major mechanism of CLABSI is colonization of the catheter with skin flora, much attention has been paid to cutaneous antisepsis. This appears to be important both at the time of central line insertion and on an ongoing basis during central line maintenance. In particular, CHG, which acts by disrupting cytoplasmic membranes and remains active hours after application, has been compared with other antiseptic solutions and is now considered the standard of care for skin antisepsis for catheter insertion and care [14 && ,15] . Bathing ICU patients older than 2 months with a CHG preparation is recommended in settings in which the CLABSI rate remains elevated despite implementation of general CLABSI prevention measures [15] . Daily bathing with 2% CHG-impregnated washcloths decreased CLABSI rates in studies of adult ICU patients [63] . Daily bathing with 4% CHG in warm water decreased methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus acquisition and healthcare-associated bloodstream infections in six ICUs at four academic medical centers [64] . In a surgical intensive care unit in which the CLABSI rate remained above the NHSN benchmark rate despite good compliance with the IHI bundle, the intervention of daily bathing with 2% CHG-impregnated cloths resulted in a 73.7% reduction in CLABSI rate (from 12.07 to 3.17 CLAB-SIs per 1000 central line-days, P ¼ 0.036). This trend was also sustained beyond the study period [65 & ]. O'Horo et al. [66 && ] recently performed a metaanalysis regarding the efficacy of daily CHG bathing of patients in adult ICUs for reduction in CLABSI rates. Twelve studies were included (one of which was a randomized controlled trial) comparing daily CHG bathing versus soap and water. Using the primary outcome of healthcare-associated bloodstream infection as defined by the individual studies, 291 patients in the CHG arm developed bloodstream infections over 67 775 patient-days, compared with 557 patients in the control arm over 69 617 catheter-days (odds ratio 0.44, P < 0.00001) [66 && ]. A sub-group analysis found no difference in efficacy between CHG liquid or CHG-impregnated cloth wipes. The authors conclude that existing data support the practice of daily CHG bathing in the ICU population for CLABSI prevention [66 && ].
TECHNOLOGY
There are few studies in the recent literature regarding use of technologies for CLABSI prevention. Given the success of the evidence-based best practices approach, most experts and national guidelines suggest the use of these technologies only in locations or populations in which unacceptably high CLABSI rates persist despite implementation of the basic CLABSI prevention strategies [14 && ,15,67] .
Antimicrobial dressings
In a multicenter randomized controlled trial, CHGimpregnated sponges were found to be effective at reducing the CLABSI rate compared with standard dressings (1.3 versus 0.4 infections per 1000 central line-days, HR 0.24, 95% CI 0.09-0.65, P ¼ 0.005) [68] . One model for determining the economic impact of use of CHG-impregnated sponge dressings suggests that a hospital inserting 3078 central lines per year is expected to avoid an average of 35 CLABSIs, 281 ICU days, and four deaths. The cost of the CHG-impregnated sponge dressings is estimated at $40 000, resulting in an estimated net annual cost savings of approximately $895 000 [69] . The CDC HICPAC guidelines and SHEA-IDSA compendium of strategies for the prevention of healthcare associated infections recommend the use of CHG-impregnated dressings for short-term catheters if the CLABSI rate does not decrease despite adherence to basic prevention measures [14 && ,15].
Coated catheters
There has been a large volume of literature published on the use of impregnated or coated catheters for CLABSI prevention. The most common antimicrobials and antiseptics used to impregnate or coat catheters include CHG-silver sulfadiazine, minocycline-rifampin, silver, and benzalkonium chloride.
Catheters coated with minocycline and rifampin have been shown to decrease CLABSI rates [70, 71] . However, concerns about development of resistance to tetracycline and rifampin remain. A recent retrospective cohort study performed at a large cancer center in the United States evaluated the effect of these coated catheters with and without other infection control measures on the rates of CLABSI and on antibiotic resistance [72 & ]. They evaluated patients admitted to the MICU during a 7-year period before and after implementing standard infection control measures. The investigators found that the use of the coated catheters significantly decreased the incidence of CLABSI in the MICU, and this decrease was independent of other infection control measures (73% further reduction compared with infection control measures alone). The use of these catheters was not associated with increased resistance of staphylococcal isolates to tetracycline and rifampin in this study [72 & ]. The SHEA-IDSA compendium recommends the use of these catheters only on units or in patient populations that have a CLABSI rate higher than the institutional goal despite compliance with the general prevention measures, in patients with a history of recurrent CLABSI, and in patients at increased risk for severe complications of CLABSI (i.e. patients with prosthetic heart valve or vascular graft) [15] . The CDC HICPAC guidelines recommend their use in patients when the catheter is expected to remain in place more than 5 days if the CLABSI rate is not decreasing despite implementation of the general prevention measures [14 && ].
Catheter lock solutions
Catheter lock solutions are used for therapeutic purposes, such as the management of CLABSI due to coagulase-negative staphylococci, but have also been investigated for use in CLABSI prevention in catheters that are not used continuously, such as hemodialysis catheters.
Most studies investigating the use of catheter lock solutions for CLABSI prevention were performed in patients with long-term or tunneled catheters or in specific patient populations, such as hemodialysis patients or neutropenic patients. In hemodialysis patients, a lock solution of 7% sodium citrate, 0.15% methylene blue, 0.15% methylparaben, and 0.015% propylparaben resulted in decreased CLABSI rate [73 & ]. The use of ethanol locks in CLABSI prevention is controversial. Two retrospective studies showed a definite reduction in CLABSI rates [74, 75] , whereas a randomized trial did not show efficacy [76] . The CDC HICPAC guidelines recommend use of lock solutions only in patients with long-term catheters who have a history of recurrent CLABSI [14 && ]; the SHEA-IDSA compendium document recommends their use only in patients with history of recurrent CLABSI and those patients at increased risk for severe sequelae from a CLABSI [15] .
CONCLUSION
Nationally, the United States has achieved outstanding success in reducing CLABSI rates in the ICU setting over the past decade. The most recent national data show that these reductions appear to be sustained and improvements continue to be observed. Most CLABSI prevention efforts have historically been focused in the ICU setting and involve a collection of evidence-based best practices for central line insertion. More recent studies suggest an added benefit from broadening prevention strategies to include evidence-based best practices for central line maintenance. CLABSI surveillance and prevention efforts are now expanded beyond the ICU to include non-ICU settings as well. CHG bathing in the ICU setting is one of the most recent strategies to be added to the CLABSI prevention arsenal. Investigation continues regarding the most effective way to implement and sustain CLABSI prevention practices, including ways to best address and improve the culture of safety in healthcare. Recent evidence suggests that similar CLABSI prevention strategies are applicable in the pediatric population and the non-ICU setting. More data are needed to develop appropriate benchmarks and prevention strategies specific to the non-ICU setting, wherein a significant proportion of central line-days and CLABSIs occur. 
